Co-ordinator
- Nov 3, 2021
- 1 min read

First patients enrolled in the SAMBAfun pilot study

The first patients have been enrolled in our clinical pilot study to evaluate the performance of the temporary epicardial pace wire with integrated sensor, CardiaSense CS1, for continuous postoperative monitoring of myocardial function after heart surgery. The clinical pilot study will be conducted at Oslo University Hospital, Rikshospitalet in Norway and Aarhus University Hospital in Denmark.

Recent Posts

See All

Approval to start clinical investigation obtained in Norway and Denmark

We are happy to announce that approvals have now been granted from both Norwegian and Danish competent authorities (Statens Legemiddelverk and Lægemiddelstyrelsen) for the SAMBAfun clinical study "A m

Clinical trial start date

Ethical commitee approvals have been acheived for the study in Norway and Denmark The consortium is now planning to start the First In Man study in Q2 2021 More updates to follow

Project presented at the 30th SSRCTS